Details about David Mark Epstein

Access statistics for papers by David Mark Epstein.

Last updated 2021-10-10. Update your information in the RePEc Author Service.

Short-id: pep15

Working Papers

2016

1. Effectiveness of treatments of varicose veins. Systematic review and evidence synthesis
   FEG Working Paper Series, Faculty of Economics and Business (University of Granada)
2. Health Related Quality of Life after Surgical Repair of Asymptomatic Abdominal Aortic Aneurysms
   FEG Working Paper Series, Faculty of Economics and Business (University of Granada)

2009

3. An economic framework for analysing the social determinants of health and health inequalities
   Working Papers, Centre for Health Economics, University of York

2008

4. Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions
   Working Papers, Centre for Health Economics, University of York View citations (3)
   See also Journal Article Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions, Journal of Health Economics, Elsevier (2010) View citations (8) (2010)

Journal Articles

2021

1. Consumers' Preferences and Willingness to Pay for Personalised Nutrition
   Applied Health Economics and Health Policy, 2021, 19, (5), 757-767 View citations (1)
2. Correction to: A general framework for classifying costing methods for economic evaluation of health care
   The European Journal of Health Economics, 2021, 22, (5), 847-847

2020

3. A general framework for classifying costing methods for economic evaluation of health care
   The European Journal of Health Economics, 2020, 21, (4), 529-542 View citations (4)

2019

4. Beyond the cost‐effectiveness acceptability curve: The appropriateness of rank probabilities for presenting the results of economic evaluation in multiple technology appraisal
   Health Economics, 2019, 28, (6), 801-807

2017

5. A Procedure for Deriving Formulas to Convert Transition Rates to Probabilities for Multistate Markov Models
   Medical Decision Making, 2017, 37, (7), 779-789 View citations (1)
6. Characterising Uncertainty in the Assessment of Medical Devices and Determining Future Research Needs
   Health Economics, 2017, 26, (S1), 109-123 View citations (6)

2016

7. Modeling the costs and long-term health benefits of screening the general population for risks of cardiovascular disease: a review of methods used in the literature
   The European Journal of Health Economics, 2016, 17, (8), 1041-1053 View citations (1)

2014

8. A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
   PharmacoEconomics, 2014, 32, (12), 1157-1170 View citations (32)
9. A comparison of the accuracy of liquid cytology versus conventional screening: a meta-analysis of split-sample studies
   Journal of the Royal Statistical Society Series A, 2014, 177, (1), 153-168
10. COMMENT ON ‘HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH’
    Health Economics, 2014, 23, (3), 374-375

2013

11. Use of Multiparameter Evidence Synthesis to Assess the Appropriateness of Data and Structure in Decision Models
    Medical Decision Making, 2013, 33, (5), 715-730

2012

12. Golimumab for the Treatment of Psoriatic Arthritis
    PharmacoEconomics, 2012, 30, (4), 257-270 View citations (22)

2010

13. Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions
    Journal of Health Economics, 2010, 29, (1), 170-181 View citations (8)
    See also Working Paper Budgetary policies and available actions: a generalisation of decision rules for allocation and research decisions, Working Papers (2008) View citations (3) (2008)

2009

14. Social determinants of health: an economic perspective
    Health Economics, 2009, 18, (5), 495-502 View citations (8)

2008

15. The hospital costs of care for stroke in nine European countries
    Health Economics, 2008, 17, (S1), S21-S31 View citations (8)
16. Uncertainty and value of information when allocating resources within and between healthcare programmes
    European Journal of Operational Research, 2008, 191, (2), 530-539 View citations (13)

2007

17. Efficiency, Equity, and Budgetary Policies
    Medical Decision Making, 2007, 27, (2), 128-137 View citations (15)

2006

18. Costs and prices for inpatient care in England: Mirror twins or distant cousins?
    Health Care Management Science, 2006, 9, (3), 233-242 View citations (11)

2005

19. Assessing the Cost-Effectiveness of New Pharmaceuticals in Epilepsy in Adults: The Results of a Probabilistic Decision Model
    Medical Decision Making, 2005, 25, (5), 493-510 View citations (5)
20. Cost-Effectiveness Analysis of Treatments for Chronic Disease: Using R to Incorporate Time Dependency of Treatment Response
    Medical Decision Making, 2005, 25, (5), 511-519 View citations (8)